MNT

MAX network transcriptional repressor, the group of MAX dimerization proteins|Basic helix-loop-helix proteins

Basic information

Region (hg38): 17:2384073-2401104

Links

ENSG00000070444NCBI:4335OMIM:603039HGNC:7188Uniprot:Q99583AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MNT gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MNT gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
clinvar
4
missense
35
clinvar
1
clinvar
36
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 35 3 2

Variants in MNT

This is a list of pathogenic ClinVar variants found in the MNT region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-2386966-C-T not specified Uncertain significance (Jan 07, 2022)2218290
17-2386992-T-C not specified Uncertain significance (Aug 11, 2024)3397316
17-2387011-C-T not specified Uncertain significance (Mar 07, 2025)3873898
17-2387050-C-T not specified Uncertain significance (Dec 14, 2024)3873900
17-2387053-C-T not specified Uncertain significance (May 09, 2024)3295472
17-2387055-G-A not specified Uncertain significance (Jun 05, 2024)3295477
17-2387059-C-G not specified Uncertain significance (Apr 01, 2024)2353819
17-2387101-C-T not specified Uncertain significance (Aug 19, 2024)3397322
17-2387109-G-T not specified Uncertain significance (Jan 18, 2025)3873903
17-2387111-C-T Benign (Jul 16, 2018)730317
17-2387137-C-T not specified Uncertain significance (May 13, 2022)2217973
17-2387164-C-A not specified Uncertain significance (Aug 01, 2024)3397319
17-2387167-G-A not specified Uncertain significance (Nov 20, 2024)3397326
17-2387188-T-C not specified Uncertain significance (Nov 06, 2023)3183861
17-2387193-G-T not specified Uncertain significance (Oct 01, 2024)3397317
17-2387194-G-A not specified Uncertain significance (Sep 14, 2023)2624419
17-2387216-C-G Likely benign (Jul 16, 2018)759878
17-2387403-G-A not specified Uncertain significance (Jun 02, 2024)3295476
17-2387405-T-C Likely benign (May 18, 2018)744718
17-2387467-G-A not specified Uncertain significance (May 15, 2024)3295475
17-2387491-G-A not specified Uncertain significance (Feb 05, 2024)3183805
17-2387583-C-T not specified Uncertain significance (Aug 05, 2024)3397321
17-2387589-T-A not specified Uncertain significance (Oct 09, 2024)3397324
17-2387610-C-T not specified Likely benign (Aug 04, 2023)2601156
17-2387916-C-A not specified Uncertain significance (Dec 03, 2024)3397315

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MNTprotein_codingprotein_codingENST00000174618 617059
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9970.0026112507901951252740.000779
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9812833330.8490.00001983615
Missense in Polyphen5075.1810.66507836
Synonymous-1.891821521.190.00001021295
Loss of Function3.87017.40.008.33e-7194

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.003250.00313
Ashkenazi Jewish0.0005040.000498
East Asian0.0007900.000762
Finnish0.001240.00120
European (Non-Finnish)0.0005040.000496
Middle Eastern0.0007900.000762
South Asian0.001010.000981
Other0.0003330.000327

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds DNA as a heterodimer with MAX and represses transcription. Binds to the canonical E box sequence 5'-CACGTG-3' and, with higher affinity, to 5'-CACGCG-3'.;

Recessive Scores

pRec
0.102

Intolerance Scores

loftool
0.0396
rvis_EVS
-0.76
rvis_percentile_EVS
13.45

Haploinsufficiency Scores

pHI
0.393
hipred
Y
hipred_score
0.748
ghis
0.605

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.891

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mnt
Phenotype
skeleton phenotype; digestive/alimentary phenotype; neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; cellular phenotype; craniofacial phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;multicellular organism development;cell aging;negative regulation of cell population proliferation;regulation of cell cycle;positive regulation of nucleic acid-templated transcription;negative regulation of apoptotic signaling pathway
Cellular component
nucleus;nucleoplasm
Molecular function
RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;chromatin binding;DNA-binding transcription factor activity;transcription coactivator activity;transcription corepressor activity;protein dimerization activity